safety of glp 1 receptor agonists Comparative efficacy and GLP-1 for weight reduction: A model-based meta-analysis of placebo-controlled trials Benefits and Risks of GLP-1

National Health and Nutrition Examination Survey

Switching back to mammalian models (hamster, rats, pigs), researchers found that GLP-1 could stimulate insulin secretion and inhibit glucagon release, which could vastly benefit diabetic patients

We therefore investigated whether oxidative stress associated with low levels of GSH could be ameliorated through the alternative strategy of increasing cellular GSH levels in diabetic patients with uncontrolled hyperglycemia

Estrogen deficiency may impair hepatic fatty acid oxidation

One recent paper found nearly 39,000 cardiovascular events were avoided when patients had access to obesity treatment, along with improvements in chronic kidney and liver diseases